Tularemia in Wildlife and Domestic Animals: Francisella tularensis Detection and Epidemiology
Etiology and Biophysical Characteristics
Tularemia is a zoonotic bacterial disease caused by Francisella tularensis, a facultative intracellular Gram-negative coccobacillus. The organism exhibits a distinctive bipolar staining pattern and is characterized by a small genome (approximately 1.9 Mb) that reflects its obligate intracellular lifestyle [1, 2]. Two primary subspecies are recognized: F. tularensis subsp. tularensis (Type A) and F. tularensis subsp. holarctica (Type B). Type A strains are predominantly found in North America and are associated with higher virulence in lagomorphs and humans, whereas Type B strains are distributed throughout the Northern Hemisphere and are commonly associated with aquatic rodent reservoirs [3, 4].
The bacterium possesses a unique lipopolysaccharide (LPS) structure that differs from typical enterobacterial LPS. Francisella LPS does not activate Toll-like receptor 4 (TLR4) effectively, allowing the pathogen to evade early innate immune recognition [5]. A polysaccharide capsule, composed of O-antigen repeats, further protects the bacterium from complement-mediated lysis and phagocytic killing [6]. The intracellular survival of F. tularensis within macrophages depends on its ability to escape the phagosome and replicate in the cytosol, a process mediated by the Francisella pathogenicity island (FPI) encoding a type VI secretion system (T6SS) [7, 8].
The bacterium is highly infectious: fewer than 10 colony-forming units (CFU) can cause clinical disease in susceptible hosts [9]. Its environmental persistence is notable, with viable organisms surviving for weeks in water, soil, and animal carcasses, particularly at low temperatures [10].
Host Range and Susceptibility
Wildlife Reservoirs
Lagomorphs (rabbits and hares) are the most classical reservoir hosts for F. tularensis. Sylvilagus species (cottontail rabbits) in North America and Lepus europaeus (European brown hare) in Eurasia exhibit high susceptibility and frequently succumb to acute fatal septicemia [11, 12]. In these species, necropsy findings typically include multifocal necrotic foci in the liver and spleen, lymphadenopathy, and splenomegaly.
Rodents serve as important maintenance hosts. Voles (Microtus spp.), muskrats (Ondatra zibethicus), and beavers (Castor canadensis) are frequently implicated in epizootic cycles [13, 14]. Waterborne transmission is particularly relevant for semiaquatic rodents, which shed bacteria in urine and contaminate surface water [15].
Other wildlife species including raccoons, skunks, opossums, and foxes can become infected but are generally considered spillover or incidental hosts [16]. Serosurveys in these species indicate exposure but low clinical attack rates relative to lagomorphs [17].
Domestic Animals
Felines. Domestic cats (Felis catus) are the most clinically relevant domestic animal species for tularemia. Cats acquire infection through hunting infected rodents or lagomorphs, or through tick exposure [18, 19]. Clinical signs include fever, depression, oral ulceration, lymphadenomegaly, and icterus. A severe form characterized by septicemia and multi-organ failure is frequently fatal without prompt antimicrobial intervention [20].
Canines. Dogs generally exhibit higher resistance to clinical disease compared to cats. Subclinical infection is common, although fever, lethargy, and cervical lymphadenopathy have been reported [21]. Dogs may serve as sentinels for environmental contamination and can mechanically transport infected ticks into peridomestic settings [22].
Livestock. Sheep, cattle, and swine are infrequently diagnosed with clinical tularemia. Experimental and natural infections in sheep can result in abortion, fever, and lameness [23]. Pigs may develop a transient febrile illness. Subclinical seroconversion is the most common outcome in cattle and horses [24, 25].
Vector Transmission and Mechanistic Pathways
F. tularensis is maintained in nature through complex vector-host interactions. Hard ticks (family Ixodidae) are the primary biological vectors. In North America, Dermacentor variabilis (American dog tick), Dermacentor andersoni (Rocky Mountain wood tick), and Amblyomma americanum (lone star tick) are confirmed vectors [26, 27]. In Eurasia, Ixodes ricinus and Dermacentor reticulatus are the principal tick species involved [28].
The biophysical mechanism of tick transmission involves bacterial colonization of the tick midgut after a blood meal from a bacteremic host. F. tularensis then disseminates to the hemolymph and subsequently to the salivary glands. Transmission to a naive host occurs during subsequent feeding, typically requiring 24 to 48 hours of attachment for bacterial replication and translocation [29, 30]. Transstadial transmission (from larva to nymph to adult) is documented, but transovarial transmission is considered inefficient and epidemiologically insignificant [31].
Biting flies, particularly deer flies (Chrysops spp.) and horse flies (Tabanus spp.), act as mechanical vectors. These insects acquire bacteria via contaminated mouthparts after interrupted feeding on an infected carcass or bacteremic host [32]. Mechanical transmission is most relevant in epizootic cycles during summer months when fly populations peak.
Mosquitoes and fleas have been implicated in some European studies, but their vector competence is considered secondary to ticks and tabanids [33]. Aerosolization of bacteria from contaminated soil or carcasses during farming, landscaping, or laboratory activities represents a non-vector mode of transmission relevant to both animals and human handlers [9].
Clinical Forms in Lagomorphs and Felines
Lagomorphs
Acute tularemia in rabbits and hares is characterized by sudden death with minimal prodromal signs. In peracute cases, animals are found deceased with no gross pathologic lesions [11]. Subacute disease presents with fever, lethargy, anorexia, and regional lymphadenopathy. Necropsy findings include an enlarged, friable spleen with military white foci, hepatic necrosis, and hemorrhagic lymph nodes. Histopathology reveals multifocal coagulative necrosis with abundant intralesional coccobacilli visible on Giemsa or Gram stain [12].
Felines
Feline tularemia has been categorized into three major clinical presentations [18, 20].
Oropharyngeal form. This is the most common form and results from ingestion of infected prey. Clinical signs include hyperthermia (exceeding 40 degrees Celsius), cervical lymphadenomegaly, tonsillar enlargement, oral ulcers, and ptyalism. Affected cats often exhibit dysphagia and reluctance to eat.
Ulceroglandular form. This form arises from bite wounds or percutaneous inoculation. A cutaneous papule or ulcer develops at the inoculation site, followed by regional lymphadenitis and abscessation. Systemic signs including fever and lethargy are variable.
Pneumonic form. Inhalation of aerosolized bacteria leads to pulmonary involvement. Clinical signs include tachypnea, cough, and hypoxemia. Thoracic radiography reveals interstitial or alveolar pulmonary infiltrates. This form carries a guarded prognosis.
Hematologic changes in infected cats include leukopenia early in the course, followed by leukocytosis with a left shift. Thrombocytopenia and elevated liver enzymes (alanine aminotransferase and alkaline phosphatase) are common biochemical abnormalities [20].
Diagnostic Methods
Serology
Serologic detection of antibodies to F. tularensis is widely used for population surveillance and retrospective diagnosis. The standard reference method is the microagglutination test (MAT), which detects IgM and IgG antibodies against whole-cell antigen [34]. A single titer of 1:128 or greater in a clinically compatible case is considered presumptive evidence of infection. A four-fold rise in paired sera confirms active infection.
The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus format has been adapted for F. tularensis antibody detection in multiple species. Commercial ELISA kits using LPS or whole-cell antigen demonstrate high sensitivity (85-95 percent) and specificity (95-99 percent) in cats, dogs, and lagomorphs [35, 36]. Cross-reactivity with Brucella species and Yersinia species is a recognized limitation, requiring confirmatory Western blot or competitive inhibition assays [37].
Molecular Detection
Real-time PCR (qPCR) targeting the fopA gene, tul4 gene, or ISFtu2 insertion sequence is the diagnostic method of choice for active infection [38, 39]. These targets provide high analytical sensitivity (detection limits of 1 to 10 genome equivalents per reaction) and species-level specificity. Multiplex qPCR panels incorporating internal amplification controls and Francisella-specific probes are routinely used in veterinary diagnostic laboratories.
Conventional PCR with amplicon sequencing of the 16S rRNA gene or the groEL gene provides subspecies-level discrimination, which is useful for molecular epidemiology and source tracking [40]. High-resolution melting (HRM) analysis of FPI-associated genes can differentiate Type A from Type B strains in a single closed-tube reaction [41].
Culture and BSL-3 Precautions
Isolation of F. tularensis in culture remains the definitive diagnostic standard but requires Biosafety Level 3 (BSL-3) facilities and trained personnel [42]. The bacterium is fastidious and requires cysteine-enriched media such as cysteine heart agar (CHA) or modified Thayer-Martin agar [43]. Colonies appear as small, smooth, grey-white growth after 24 to 72 hours of incubation at 37 degrees Celsius in 5 percent carbon dioxide. Biochemical identification relies on weak catalase activity, oxidase negativity, and beta-lactamase production [44].
Strict adherence to BSL-3 containment is mandatory because laboratory-acquired infections are well documented [45]. All specimen processing (including centrifugation, vortexing, and culture manipulation) must be performed in a Class II biological safety cabinet. Personnel must wear double gloves, a fluid-resistant gown, and respiratory protection (N95 or powered air-purifying respirator).
Point-of-Care Considerations
Point-of-care lactate and blood gas analyzers have been evaluated in canine emergency triage for sepsis assessment but are not specific for tularemia [46]. In field settings, lateral flow immunochromatographic assays targeting F. tularensis antigen in tissue homogenates or lymph node aspirates have been developed, but their sensitivity relative to qPCR remains suboptimal [47].
Diagnostic Workflow
The following Mermaid diagram illustrates a recommended diagnostic algorithm for suspected tularemia in a wildlife or domestic animal case.
flowchart TD
A[Clinical suspicion: fever,\nlymphadenopathy, oral ulcers,\nor sudden death in lagomorph or cat], > B[Collect samples: whole blood,\nlymph node aspirate, tissue biopsy,\nor swab of oral lesion]
B, > C{BSL-3 lab available?}
C, >|Yes| D[Perform culture on CHA\nand qPCR for fopA/tul4]
C, >|No| E[Submit to reference lab;\nstore samples at 4°C]
D, > F{qPCR positive?}
F, >|Yes| G[Confirm with sequencing\nor HRM for subspecies]
F, >|No| H[Consider serology\n(acute and convalescent sera)]
G, > I[Report case to\nveterinary public health authority]
H, > I
D, > J{Culture positive?}
J, >|Yes| K[Antimicrobial susceptibility\ntesting (optional)]
J, >|No| L[Serologic confirmation if\nclinical signs persist]
K, > I
L, > I
Epidemiology and Ecological Drivers
Tularemia exhibits a pronounced seasonal pattern, with peak incidence in late spring to early autumn, correlating with tick and biting fly activity [48]. Epizootics in lagomorph populations can result in local extinction events, particularly in fragmented habitats where population density is low and transmission efficiency is high [11].
Environmental factors influencing F. tularensis persistence include water pH, temperature, and organic carbon content. The bacterium survives for extended periods in neutral to slightly alkaline water (pH 6.5 to 8.0) at temperatures below 15 degrees Celsius [14]. Protozoan hosts, particularly Acanthamoeba species, can support intracellular survival and replication of F. tularensis, contributing to environmental maintenance in aquatic ecosystems [49].
Land use change and habitat fragmentation alter host-vector contact rates. Agricultural expansion into grassland and forest-edge habitats increases overlap between domestic animals, wildlife, and ixodid tick populations [50]. Climate change models predict northward expansion of Dermacentor and Ixodes species ranges, potentially introducing F. tularensis into naive animal populations [28].
Zoonotic Risk and One Health Implications
F. tularensis is classified as a Tier 1 select agent due to its low infectious dose and potential for weaponization. Veterinary personnel, wildlife rehabilitators, hunters, and laboratory workers are at elevated occupational risk [9]. Direct transmission occurs through skin contact with infected animal tissues, inhalation of aerosolized bacteria, and arthropod bites.
Domestic cats pose a particular zoonotic risk because they frequently bring infected prey into households and can transmit F. tularensis through bites, scratches, or direct contact with oral secretions [18]. Veterinarians treating cats with suspected tularemia should implement standard and contact precautions, including gloves, gowns, and eye protection.
Carcass handling of wild lagomorphs by hunters is a well documented exposure route. Freezing does not reliably inactivate F. tularensis; therefore, hunters should wear gloves during skinning and use thorough cooking of meat to eliminate risk [9].
A One Health surveillance framework integrating wildlife serosurveys, tick pathogen screening, and domestic animal case reporting is critical for early detection of epizootic activity. Molecular typing of isolates from wildlife, vectors, and domestic animals provides data on transmission networks and informs risk assessment models [50].
Conclusions
Tularemia remains an important but underdiagnosed bacterial disease in wildlife and domestic animal populations. Detection requires a high index of clinical suspicion, appropriate sample collection, and access to molecular diagnostic tools operating under BSL-3 containment for culture. Vector ecology, host susceptibility, and environmental persistence drive complex transmission dynamics that vary across geographic regions. Integration of veterinary diagnostics, wildlife surveillance, and molecular epidemiology is essential for understanding and mitigating the impact of F. tularensis on animal health and zoonotic transmission risk.
References
[1] Sjostedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:1-29.
[2] Larsson P, Oyston PC, Chain P, et al. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet. 2005;37(2):153-159.
[3] Farlow J, Wagner DM, Dukerich M, et al. Francisella tularensis in the United States. Emerg Infect Dis. 2005;11(12):1835-1841.
[4] Vogler AJ, Birdsell D, Price LB, et al. Phylogeography of Francisella tularensis: global expansion of a highly fit clone. J Bacteriol. 2009;191(8):2474-2484.
[5] Hajjar AM, Harvey MD, Shaffer SA, et al. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun. 2006;74(12):6730-6738.
[6] Apicella MA, Post DM, Fowler AC, et al. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS One. 2010;5(7):e11060.
[7] Nano FE, Zhang N, Cowley SC, et al. A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol. 2004;186(19):6430-6436.
[8] Lindgren H, Shen H, Zingmark C, et al. Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species. Infect Immun. 2007;75(1):310-317.
[9] Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285(21):2763-2773.
[10] Parker RR, Spencer RR. Studies on experimental tularemia. Public Health Rep. 1926;41:1341-1355.
[11] Morner T. The ecology of tularemia. Rev Sci Tech. 1992;11(4):1123-1130.
[12] Bell JF, Stewart SJ. Tularemia in North America. Bull Wildl Dis Assoc. 1966;2(3):67-76.
[13] Jellison WL. Tularemia in North America, 1930-1974. Univ Mont Biol Publ. 1974;6:1-276.
[14] Berdal BP, Mehl R, Meidell NK, et al. Field investigations of tularemia in Norway. FEMS Immunol Med Microbiol. 1996;13(2):135-139.
[15] Parker RR, Davis GE. Tularemia in beavers and muskrats. Public Health Rep. 1935;50:377-381.
[16] Petersen JM, Mead PS, Schriefer ME. Francisella tularensis: an arthropod-borne pathogen. Vet Res. 2009;40(2):7.
[17] Baker LA, Jenney EW, Wilson ME. Serologic survey of wild mammals for tularemia. J Wildl Dis. 1970;6(4):347-350.
[18] Foley JE, Nieto NC, Lee J, et al. Tularemia in domesticated cats. J Feline Med Surg. 2005;7(5):289-295.
[19] Liles WC, Burger WC. Feline tularemia: a case report and review of the literature. J Am Anim Hosp Assoc. 1993;29(4):350-353.
[20] Baldwin CJ, Panciera RJ, Morton RJ, et al. Acute tularemia in three domestic cats. J Am Vet Med Assoc. 1991;199(11):1602-1605.
[21] Rhyan JC, Gahagan T, Fales WH. Tularemia in a dog. J Am Vet Med Assoc. 1990;197(12):1561-1562.
[22] Levi MH, Glaser C, Jones JH, et al. Canine tularemia in California. J Vet Diagn Invest. 2000;12(4):368-371.
[23] Torgensen J, Petersen I. Tularemia in sheep. Acta Vet Scand. 1953;5:1-10.
[24] Sandstedt K, Moore R, Hornfeldt B, et al. Serologic survey of cattle for Francisella tularensis in Sweden. J Wildl Dis. 2003;39(2):399-403.
[25] Jellison WL, Kohls GM, Butler WJ, et al. Tularemia in horses. J Am Vet Med Assoc. 1942;101:106-108.
[26] Eisen L. Pathogen persistence in the environment and insect vectors: different ecological niches for Francisella tularensis. Microbes Infect. 2007;9(10):1242-1249.
[27] Goethert HK, Telford SR III. Nonviral tick-borne infections in humans. Emerg Infect Dis. 2009;15(10):1627-1628.
[28] Hubalek Z, Halouzka J. Tick-borne tularemia in Europe. Eur J Epidemiol. 1997;13(3):303-308.
[29] Hopla CE. Experimental transmission of tularemia by the lone star tick. Am J Hyg. 1955;61(2):219-227.
[30] Burgdorfer W, Varma MG. Trans-stadial and transovarial development of disease agents in arthropods. Annu Rev Entomol. 1967;12:347-376.
[31] Reif KE, Stout RW, Henry GC, et al. Absence of transovarial transmission of Francisella tularensis in Dermacentor variabilis ticks. J Med Entomol. 2011;48(2):381-385.
[32] Jellison WL, Kohls GM. Tularemia in sheep and deer flies. Public Health Rep. 1950;65(54):1731-1737.
[33] Petersen JM, Schriefer ME. Tularemia: emergence/re-emergence. Vet Res. 2005;36(3):455-467.
[34] Sato T, Fujita H, Ohara Y, et al. Microagglutination test for serodiagnosis of tularemia. J Clin Microbiol. 1990;28(12):2719-2721.
[35] Porsch-Ozcurumez M, Kischel N, Priebe HS, et al. Evaluation of an immunochromatographic test for the detection of Francisella tularensis antibodies in wild animals. Vet Microbiol. 2004;100(1-2):129-135.
[36] Splettstoesser WD, Matz-Rensing K, Seibold E, et al. Re-emergence of Francisella tularensis in Germany. Emerg Infect Dis. 2007;13(7):1039-1041.
[37] Bevanger L, Maeland JA, Kvan AI. Cross-reactivity between Francisella tularensis and Brucella species. APMIS. 1994;102(7):513-518.
[38] Versage JL, Severin DD, Chu MC, et al. Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis. J Clin Microbiol. 2003;41(12):5492-5499.
[39] Kugeler KJ, Pappert R, Zhou Y, et al. Real-time PCR for Francisella tularensis types A and B. Emerg Infect Dis. 2005;11(9):1452-1454.
[40] Birdsell DN, Vogler AJ, Buchhagen J, et al. TaqMan real-time PCR assays for single-nucleotide polymorphisms that identify Francisella tularensis subspecies and subtypes. J Clin Microbiol. 2014;52(5):1576-1583.
[41] Tomaso H, Reisinger EC, Al Dahouk S, et al. Rapid differentiation of Francisella tularensis subspecies by high-resolution melting analysis. J Clin Microbiol. 2012;50(6):2093-2095.
[42] Centers for Disease Control and Prevention. Biosafety in microbiological and biomedical laboratories. 6th ed. HHS Publication No. (CDC) 300859. 2020.
[43] Petersen JM, Schriefer ME, Gage KL, et al. Methods for enhanced culture recovery of Francisella tularensis. Appl Environ Microbiol. 2004;70(7):4292-4295.
[44] Chu MC, Weyant RS. Francisella. In: Murray PR, Baron EJ, Jorgensen JH, et al., editors. Manual of clinical microbiology. 9th ed. ASM Press; 2007. p. 871-881.
[45] Shapiro DS, Schwartz DR. Exposure of laboratory workers to Francisella tularensis despite a bioterrorism preparedness exercise. J Clin Microbiol. 2002;40(11):4279-4281.
[46] Acierno MJ, Hitt ME, Scherk MA, et al. Point-of-care lactate and blood gas analyzers in canine emergency triage. J Vet Emerg Crit Care. 2008;18(4):361-368.
[47] Splettstoesser WD, Tomaso H, Al Dahouk S, et al. Diagnostic procedures in tularemia. Dtsch Tierarztl Wochenschr. 2007;114(9):352-356.
[48] Eliasson H, Lindback J, Nuorti JP, et al. The 2000 tularemia outbreak in Sweden. Emerg Infect Dis. 2002;8(10):1029-1032.
[49] Abd H, Johansson T, Golovliov I, et al. Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol. 2003;69(1):600-606.
[50] Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16(1):113-124.